Form 4: Orchestra BioMed Holdings CFO Reports Stock Transaction
Insider Transaction (Form 4)
Andrew Lawrence Taylor, Chief Financial Officer of Orchestra BioMed Holdings, Inc., reported a transaction in 3,076 shares of common stock on August 26, 2026.
Summary
- Tax/exercise-price withholding: disposed of 3,076 Common Stock, par value $0.0001 per share at $5.26 ($16,180) on August 26, 2026; holds 589,989 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Andrew Lawrence Taylor — Officer (Chief Financial Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-26 | Tax/exercise-price withholding | Common Stock, par value $0.0001 per share | 3,076 | $5 | $16.2K | 589,989 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-26 | Tax/exercise-price withholding (3,076 shares) |
Keywords
insider transaction, Form 4, OBIO, Orchestra BioMed Holdings, Inc., neutral, Andrew Lawrence Taylor
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.